Skip to content
All guides
Harm reduction

Psychedelic Safety Checklist: Before, During, and After

What to check about a retreat or licensed session before you book, on the day and afterwards: licence, screening, staff, emergency plan, consent, the law and aftercare.

Editorial Team6 min readUpdated

A good retreat or licensed session is mostly decided before you arrive. This checklist covers what to check about the provider, yourself, the place and the aftercare. It does not repeat the medical questions: start with the screening checklist, which covers heart, mental health, medicines and pregnancy with the source behind each question, and the interaction checker if you take any medicine. Come back here once you know that a session is medically reasonable for you.

Why you have to check for yourself

In most places nobody inspects a psychedelic ceremony. The Dutch Trimbos Institute notes that no one checks whether ceremony guidance is in order, including intake, aftercare or the number of sober people present. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut) The exceptions are regulated programmes such as Oregon's licensed psilocybin services and Colorado's licensed healing centres. (Oregon Health Authority, current page; Colorado General Assembly, 23 May 2023; Colorado Department of Revenue, Natural Medicine Division, 2 Apr 2025) Where no regulator checks, every item below is your job.

The provider: before you pay a deposit

Licence and legal standing

Medical screening, and who reviews it

  • Does screening happen before payment, and who reads it? A form that nobody medically qualified reviews is paperwork, not screening.
  • For ibogaine, an ECG, and potassium and magnesium checks are the minimum. The Global Ibogaine Therapy Alliance guidelines exclude a prolonged QTc and say a QTc over 500 ms during treatment requires immediate hospital transfer. (Global Ibogaine Therapy Alliance (Internet Archive copy), 2016)
  • For ayahuasca, ask how the centre handles antidepressants. Combining ayahuasca with an SSRI may cause serotonin syndrome, and stopping a psychiatric medicine is itself risky and should only happen under strict medical supervision. (Journal of Psychoactive Drugs, 1998; ICEERS, 2026; ICEERS, 2018) The details are in ayahuasca and antidepressants. A centre that tells you to stop a medicine on its own timetable is a red flag; that decision belongs to your prescriber.

Staff and training

Emergency plan

Consent, touch and conduct

Yourself

The screening checklist has the medical questions. Beyond those:

  • Tell the provider everything, including supplements and recreational drugs. If they do not ask, that tells you about their screening.
  • Do not change any medicine without your prescriber. If a provider says you must, take that conversation to the person who prescribed it.
  • Arrange support at home for the days after, and keep the week after free of big commitments.
  • Know your reasons. Dutch drug information services say ceremonies advertised as treatment for mental health problems are not therapy and that many people have more complaints afterwards. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut) If you want treatment, look at conditions and clinical trials.

The place and the law

A retreat advertising openly tells you nothing certain about its legal position. Psilocybin is in Schedule I of the 1971 Convention on Psychotropic Substances, and other active ingredients are controlled too. (Transnational Institute (copy of statute), 2001; Instituto Costarricense sobre Drogas, current page; International Narcotics Control Board, Mar 2011) The plants and brews themselves are not under international control, but the International Narcotics Control Board recommends that governments control them nationally where necessary, so international non-control does not mean national legality. (International Narcotics Control Board, Mar 2011) Some examples of how differently countries handle this:

The legal status page covers each country. Wild peyote is not on offer here: it is Vulnerable, it is the Native American Church's sacrament, and the site points mescaline interest to cultivated San Pedro instead. See the peyote position. (IUCN Red List, 2017; eCFR, current)

Red flags that should end the conversation

Some answers are enough on their own to walk away:

On the day

After the session

Integration

Oregon requires facilitators to contact each client within 72 hours of the session to review the safety plan, record any reactions and offer optional integration sessions. (Oregon Health Authority, Public Health Division, May 2025) Ask any provider what follow-up they offer, and who you can call a week later. The integration practices article covers what that work looks like.

Warning signs

Hard days after a session are common. In the Global Ayahuasca Survey, 55.9% reported adverse mental health effects in the following weeks or months; most saw them as part of a positive process, but around 12% sought professional support. (PLOS Global Public Health, 2022) Get help if you notice:

If any of these apply, see a doctor and tell them what you took.

If you are weighing a retreat, Rythmia offers ayahuasca in Costa Rica and is a Peyote.com partner.

Related

Questions and answers

What should I ask a psychedelic retreat before booking?
Ask who reviews your medical screening and when, how many sober trained staff are present per participant, whether a doctor or nurse is on site, what the emergency plan is and how far the hospital is, what the touch and consent policy is, and every substance on the programme. Nobody checks most ceremonies, so these answers are your only quality control.Source: DRUGSinfo (Drugs Infolijn), Trimbos-instituutPre-retreat screening checklist
Do psychedelic facilitators need a licence?
Only where a regulated programme exists. In Oregon, facilitators must complete approved training with a practicum, pass a state exam and a background check, and psilocybin may only be taken at a licensed service centre. Colorado licenses facilitators and healing centres. Most retreats abroad have no comparable facilitator licence.Sources: Oregon Health Authority, Public Health Division, May 2025; Oregon State Legislature, current edition; Colorado General Assembly, 23 May 2023; Colorado General Assembly, 23 May 2023; Colorado Lawyer (Colorado Bar Association)
Can a facilitator touch me during a psychedelic session?
Only with your agreement, and within limits. Oregon's rules restrict the kinds of supportive touch and require the client's consent before the session. Chacruna's community guide says traditional practices such as plant baths do not involve touching private parts or require nudity, and that sexual contact between healer and participant during or after ceremonies is not acceptable.Sources: Oregon Health Authority, Public Health Division, May 2025; Chacruna Institute for Psychedelic Plant Medicines, 2018
Is it normal to feel worse after a psychedelic retreat?
Difficult weeks afterwards are common: 55.9% of Global Ayahuasca Survey respondents reported adverse mental health effects, and around 12% of them sought professional support. Distress that is not easing, mania or sleeplessness, or thoughts of self-harm are reasons to see a doctor; in the US, 988 is the crisis line.Source: PLOS Global Public Health, 2022

Sources

  1. Paddo's: Risico's. DRUGSinfo (Drugs Infolijn), Trimbos-instituut
  2. Oregon Psilocybin Services: Health and Safety (fact sheet). Oregon Health Authority, Public Health Division, May 2025
  3. Report of the International Narcotics Control Board for 2010 (paras 284-287). International Narcotics Control Board, Mar 2011
  4. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Global Public Health, 2022
  5. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. Journal of Psychopharmacology, 2023
  6. Oregon Psilocybin Services. Oregon Health Authority, current page
  7. Senate Bill 23-290 (signed act). Colorado General Assembly, 23 May 2023
  8. The DOR's Natural Medicine Division issues Colorado's first healing center license. Colorado Department of Revenue, Natural Medicine Division, 2 Apr 2025
  9. ORS Chapter 475A - Psilocybin. Oregon State Legislature, current edition
  10. SB23-290 Natural Medicine Regulation And Legalization. Colorado General Assembly, 23 May 2023
  11. Colorado's Bold Move to Legalize Psychedelics. Colorado Lawyer (Colorado Bar Association)
  12. Medicines Classification Committee, Minutes of the 42nd Meeting (3 November 2009), item 10.1 Ibogaine and its metabolite noribogaine. Medsafe, New Zealand Ministry of Health, 2009
  13. Monitoring of patient following administration of an unapproved, prescription-only medication (13HDC00966). New Zealand Health and Disability Commissioner, 2015
  14. Que es la ibogaina, la sustancia psicodelica .... Infobae Mexico, 21 Sep 2026
  15. Clinical Guidelines for Ibogaine-Assisted Detoxification, 1st Edition, Version 1.1. Global Ibogaine Therapy Alliance (Internet Archive copy), 2016
  16. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. Journal of Psychoactive Drugs, 1998
  17. Ayahuasca Safety Profile. ICEERS, 2026
  18. Deciding to Take Ayahuasca. ICEERS, 2018
  19. Oregon Psilocybin Services 2025 Year-End Data Summary Document. Oregon Health Authority, 2026
  20. Ayahuasca Community Guide for the Awareness of Sexual Abuse. Chacruna Institute for Psychedelic Plant Medicines, 2018
  21. Examining the Deaths Misattributed to Ayahuasca. ICEERS, 2023
  22. A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. Journal of Analytical Toxicology, 2005
  23. Ley 8204 (text). Transnational Institute (copy of statute), 2001
  24. Ley 8204. Instituto Costarricense sobre Drogas, current page
  25. Lei n.o 30/2000, de 29 de Novembro. Diario da Republica, I Serie-A, n.o 276, 29 Nov 2000
  26. Cogumelos magicos: Prevencao do consumo de substancias estupefacientes. Policia Judiciaria, current page
  27. Resolucao No 1, de 25 de janeiro de 2010 (CONAD). Ministerio da Justica e Seguranca Publica / Diario Oficial da Uniao, 25 Jan 2010
  28. Codigo Penal Federal (texto vigente, ultima reforma DOF 13-03-2026). Camara de Diputados del H. Congreso de la Union, 13 Mar 2026
  29. Lophophora williamsii (Terry, M.), IUCN Red List of Threatened Species 2017. IUCN Red List, 2017
  30. 21 CFR 1307.31 - Native American Church. eCFR, current
  31. Fatalities temporally associated with the ingestion of ibogaine. Journal of Forensic Sciences, 2012
  32. 21 CFR 1308.11 - Schedule I. eCFR (Office of the Federal Register), current
  33. Psychedelic Drugs: Considerations for Clinical Investigations (final guidance, July 2026). U.S. Food and Drug Administration, Jul 2026
  34. Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review. Psychiatry Research, 2024
  35. [Ayahuasca in the Netherlands: what the doctor should know about its side effects]. Nederlands Tijdschrift voor Geneeskunde, 2020
  36. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 2016
  37. Hallucinogen persisting perception disorder: what do we know after 50 years?. Drug and Alcohol Dependence (Halpern JH, Pope HG), 2003

The dispatch

Laws change. Centres change. Know before you book.

A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.

Educational only. Not medical advice. Unsubscribe any time.